Amit Verma

28PUBLICATIONS
117CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|May 13, 2026
Chromatin rewiring of β-globin and MYC enhancers by TGF-β1 drives defective erythropoiesis.

|Aug 21, 2025
Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification.

Rajvi Gor, Jeevan Shivakumar, Pallavi Surana

|Jul 25, 2025
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected Cases.

Nishi Shah, Melissa Suchanek, Astha Thakkar

|Feb 07, 2025
Venetoclax plus daunorubicin and cytarabine for newly diagnosed acute myeloid leukemia: results of a phase 1b study.

Ioannis Mantzaris, Mendel Goldfinger, Matan Uriel

|Jan 09, 2025
Advancing drug development in myelodysplastic syndromes.

Alain Mina, Kathy L McGraw, Lea Cunningham

|Sep 24, 2024
A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohort.

Mendel Goldfinger, Ioannis Mantzaris, Aditi Shastri

Pageof 5

Frequent Collaborators

5 joint publications

Aditi Shastri

5 joint publications

Ulrich Steidl

4 joint publications

Nishi Shah

3 joint publications

Rami S Komrokji